Literature DB >> 26628625

Long-term visual acuity, retention and complications observed with the type-I and type-II Boston keratoprostheses in an Irish population.

E S Duignan1, S Ní Dhubhghaill2, C Malone1, W Power1.   

Abstract

AIM: To evaluate the outcomes of the type-I and type-II Boston keratoprostheses in a single Irish centre.
METHODS: A retrospective chart review of keratoprosthesis implantations carried out in our institution from November 2002 to March 2014 was performed. All procedures were performed by a single surgeon (WP).
RESULTS: Thirty-four keratoprosthesis implantations were carried out in 31 patients with a mean follow-up of 42±31 months (range 2-110 months). Seventeen patients were female (54.8%) and 14 were male (45.2%). The majority of keratoprostheses implanted were type-I (31/34, 91.2%), and three were type-II (3/34, 8.8%). Twenty-nine patients (85.3%) had an improvement in distance best-corrected visual acuity (BCVA) from baseline. Fifty per cent (17/34) of patients had a best-ever BCVA of at least 6/12. Eighteen patients (64.3%) retained a BCVA of at least 6/60 at 1 year. Over the course of follow-up, six keratoprostheses were explanted from six eyes of five patients, one of which was a type-II keratoprosthesis. Twenty-six patients (76.5%) developed postoperative complications. Complications included retroprosthetic membrane (18 patients, 52.9%), an exacerbation or new diagnosis of glaucoma (6 patients, 17.6%), endophthalmitis (5 patients, 14.7%) and retinal detachment (2 patients, 5.9%).
CONCLUSIONS: These data demonstrate excellent visual acuity and retention outcomes in a cohort with a long follow-up period in a single centre. Complications remain a considerable source of morbidity. These outcomes provide further evidence for the long-term stability of type-I and type-II Boston keratoprostheses in the management of patients in whom a traditional graft is likely to fail. Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://www.bmj.com/company/products-services/rights-and-licensing/

Entities:  

Keywords:  Cornea; Prosthesis; Treatment Surgery

Mesh:

Year:  2015        PMID: 26628625     DOI: 10.1136/bjophthalmol-2015-307443

Source DB:  PubMed          Journal:  Br J Ophthalmol        ISSN: 0007-1161            Impact factor:   4.638


  3 in total

1.  Three-Dimensional Construction of a Rabbit Anterior Corneal Replacement for Lamellar Keratoplasty.

Authors:  Kunpeng Pang; Liqun Du; Kai Zhang; Chenyang Dai; Chengqun Ju; Jing Zhu; Xinyi Wu
Journal:  PLoS One       Date:  2016-12-08       Impact factor: 3.240

Review 2.  Keratoprosthesis: Current global scenario and a broad Indian perspective.

Authors:  Geetha Iyer; Bhaskar Srinivasan; Shweta Agarwal; Deepti Talele; Ekta Rishi; Pukhraj Rishi; Sripriya Krishnamurthy; Lingam Vijaya; Nirmala Subramanian; Shanmugasundaram Somasundaram
Journal:  Indian J Ophthalmol       Date:  2018-05       Impact factor: 1.848

3.  Recurrent cystoid macular edema following Boston keratoprosthesis type-II implantation: A treatment option.

Authors:  Samar K Basak; Soham Basak
Journal:  Indian J Ophthalmol       Date:  2020-08       Impact factor: 1.848

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.